Agios up as FDA gives Thermo Fisher glioma test breakthrough status

Agios up as FDA gives Thermo Fisher glioma test breakthrough status

Submitted by admin on June 16, 2020 - 10:35am
Source: 
Pharmaforum
News Tags: 
Agios Pharmaceuticals
FDA
vorasidenib
brain cancer
glioma
Headline: 
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
snippet: 

Shares in Agios Pharma ticked upwards after the FDA awarded breakthrough status to a companion diagnostic to vorasidenib, its experimental drug for brain cancer.

Do Not Allow Advertisers to Use My Personal information